Beta Cell Dedifferentiation in Type 1 Diabetes: Sacrificing Function for Survival?
Overview
Affiliations
The pathogeneses of type 1 and type 2 diabetes involve the progressive loss of functional beta cell mass, primarily attributed to cellular demise and/or dedifferentiation. While the scientific community has devoted significant attention to unraveling beta cell dedifferentiation in type 2 diabetes, its significance in type 1 diabetes remains relatively unexplored. This perspective article critically analyzes the existing evidence for beta cell dedifferentiation in type 1 diabetes, emphasizing its potential to reduce beta cell autoimmunity. Drawing from recent advancements in both human studies and animal models, we present beta cell identity as a promising target for managing type 1 diabetes. We posit that a better understanding of the mechanisms of beta cell dedifferentiation in type 1 diabetes is key to pioneering interventions that balance beta cell function and immunogenicity.
Multi-omics analysis of long-term cultured human islets.
Sun G, Qi M, Sun O, Lizhar E, Hussey D, Shi Y bioRxiv. 2025; .
PMID: 39763987 PMC: 11703225. DOI: 10.1101/2024.12.25.626491.